Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Norethindrone + ethinyl oestradiol + ferrous fumarte |
Is a |
Product containing ethinylestradiol (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Norethindrone + ethinyl oestradiol + ferrous fumarte |
Is a |
Product containing ferrous fumarate (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Norethindrone + ethinyl oestradiol + ferrous fumarte |
Is a |
Norethisterone-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Norethindrone + ethinyl oestradiol + ferrous fumarte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Iron (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Norethindrone + ethinyl oestradiol + ferrous fumarte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ethinylestradiol (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Norethindrone + ethinyl oestradiol + ferrous fumarte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Norethisterone acetate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Norethindrone + ethinyl oestradiol + ferrous fumarte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Estradiol |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Norethindrone + ethinyl oestradiol + ferrous fumarte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ferrous fumarate (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Norethindrone + ethinyl oestradiol + ferrous fumarte |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Norethindrone + ethinyl oestradiol + ferrous fumarte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Progesterone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Norethindrone + ethinyl oestradiol + ferrous fumarte |
Is a |
Oral oestradiol |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|